Skip to main content

Now Open:

2016 Broad Agency


Broad Agency Announcements for Advanced Research and Development of
Medical Countermeasures for Pandemic Influenza and Chemical, Biological,
Radiological and Nuclear Threats.

Learn More

Recent Publications

Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan 2015

The United States (U.S.) continues to face a range of serious threats to its national health security from the deliberate use or accidental release of chemical, biological, radiological, and nuclear (CBRN) agents, as well as from naturally occurring and emerging infectious diseases (EID), including pandemic influenza....

Project BioShield Report 2014

Significant progress was made in 2014 in the regulatory review and approval of MCMs procured under Project BioShield...

Project BioShield Report 2013

The Project BioShield Act of 2004 [Project BioShield (PBS); Public Law [P.L.] 108-276] amended the Public Health Service (PHS) Act and the Federal Food, Drug, and Cosmetic (FD&C) Act to provide additional and more flexible authorities and funding to support financially the development and procurement of medical countermeasures....

Project BioShield Annual Report to Congress 2012

The Medical Countermeasures (MCM) Enterprise had a significant year in 2012. The U.S. Department of Health and Human Services’ (HHS) continued to leverage recommendations of the “Public Health Emergency Medical Countermeasures Enterprise Review...

PHEMCE Implementation Plan 2012

The 2012 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan describes the priorities that HHS, in collaboration with its interagency partners, will implement over the next five years to advance ...
View All Publications